Search Results 381-390 of 16176 for pharmacogenetics
Mayo Clinic's Immuno-Epigenetics Lab studies the pathophysiology of inflammatory bowel disease and how the adaptive immune system contributes to intestinal ...
The purpose of this study is to identify subtype-specific signatures for breast cancer using genomic positioning of plasma DNA fragments, and to validate ...
About this study. The purpose of this study is to assess the ability to successfully create numerous validated patient-derived xenograft (PDX) models from ...
Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “D” to learn about drug side effects, proper use and ...
About this study. This study aims to establish, use, and extensively share a comprehensive longitudinal resource of genetic, non-genetic, and cognitive data ...
Mayo Clinic's Phospholipid Signaling in Embryonic Development and Human Diseases Lab led by Kun Ling, Ph.D., studies phosphoinositide species and enzymes in ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Mutations in genes can lead to uncontrolled cell growth and cancer. Patients with a greater than 30% mutation to any of the following genes; CDKN2C, FGFR3, KRAS ...
Research teams combine multi-omic technologies and data to develop precision diagnostics and therapeutics for patients with various types of cancers, rare ...
Pharmacokinetic pharmacogenetic prescribing guidelines for antidepressants: A template for psychiatric precision medicine. Mayo Clinic Proceedings. 2016 ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.